剖宫产瘢痕妊娠:高强度聚焦超声与子宫动脉栓塞治疗疗效及耐受性比较
回顾性队列研究比较31例高强度聚焦超声(HIFU)与45例子宫动脉栓塞(UAE)治疗剖宫产瘢痕妊娠。UAE组术后首日β-hCG显著下降,残留病灶3–17周消失,1例行子宫切除,2例宫腔粘连且月经未恢复正常。HIFU组β-hCG多先升高后2–12周降至正常,病灶3–14周脱落,无需刮宫,3–9周月经恢复,疼痛更少、并发症更少、无需住院麻醉且费用更低。
要点
- HIFU组β-hCG不快速下降,多先升高后2–12周降至正常,病灶3–14周脱落。
- UAE组术后首日β-hCG显著下降,残留病灶3–17周消失。
- HIFU组疼痛更少、并发症更少、无需住院麻醉且费用更低。
核心结论
- HIFU是高效、耐受性好且无创的剖宫产瘢痕妊娠治疗方法,与UAE相比疼痛更少、并发症更少、无需住院麻醉且费用更低。
研究设计与样本
- 回顾性队列研究,HIFU组31例,UAE组45例,比较治疗与恢复情况并随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The aim of this study was to investigate the clinical efficacy of high-intensity focused ultrasound (HIFU) for the treatment of a cesarean scar pregnancy compared with uterine artery embolization (UAE) and intra-arterial methotrexate infusion combined with uterine curettage. In this retrospective cohort study, 31 patients were treated with HIFU (HIFU group), and 45 patients were treated with UAE (UAE group). We compared the treatment and recovery of the patients, including follow-up. After UAE treatment, serum levels of the β subunit of human chorionic gonadotropin declined significantly on the first day, and the residual lesions disappeared in 3-17 wk. One patient underwent hysterectomy; intrauterine adhesions were found by hysteroscopic examination after 6 mo in 2 patients, whose menstrual function did not return to normal. The remainder of the 42 patients recovered normal menstrual functioning during the 3- to 18-wk follow-up. In the patients who underwent HIFU treatment, serum β-HCG levels did not decline rapidly; serum β-HCG levels increased in many patients and then declined to normal steadily within 2-12 wk. Lesions detached in 3-14 wk in all patients, and menstrual functioning was recovered in 3-9 wk without uterine curettage. Compared with the UAE group, the HIFU group had less pain and fewer complications; the patients in the HIFU group were not hospitalized or anesthetized and had lower costs. HIFU is an efficient, tolerable and non-invasive treatment.
引用
- Xiao J, Shi Z, Zhou J, et al. Cesarean Scar Pregnancy: Comparing the Efficacy and Tolerability of Treatment with High-Intensity Focused Ultrasound and Uterine Artery Embolization. Ultrasound Med Biol. 2016. PMID: 27979666. doi:10.1016/j.ultrasmedbio.2016.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。